Targeting	NN
genes	NNS
for	IN
treatment	NN
in	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
:	:
challenges	NNS
and	CC
opportunities	NNS
,	,
promises	NNS
and	CC
pitfalls	NNS
.	.

The	DT
currently	RB
accepted	VBN
approach	NN
to	TO
treatment	NN
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
based	VBN
on	IN
the	DT
assumption	NN
that	IN
it	PRP
is	VBZ
a	DT
chronic	JJ
inflammatory	JJ
disease	NN
,	,
and	CC
most	JJS
available	JJ
antiinflammatory	JJ
drugs	NNS
target	VBP
numerous	JJ
biological	JJ
processes	NNS
involving	VBG
multiple	JJ
genes	NNS
,	,
but	CC
are	VBP
not	RB
often	RB
beneficial	JJ
.	.

More	RBR
novel	JJ
therapeutic	JJ
strategies	NNS
take	VBP
recent	JJ
findings	NNS
about	IN
the	DT
underlying	VBG
molecular	JJ
mechanisms	NNS
of	IN
fibrogenesis	NN
into	IN
account	NN
,	,
and	CC
ongoing	JJ
and	CC
as	RB
yet	RB
unpublished	JJ
clinical	JJ
trials	NNS
in	IN
IPF	NN
aim	NN
to	TO
block	VB
single	JJ
gene	NN
targets	VBZ
believed	VBN
to	TO
play	VB
major	JJ
roles	NNS
in	IN
disease	NN
progression	NN
.	.

Characterization	NN
of	IN
the	DT
mechanisms	NNS
involved	VBN
in	IN
the	DT
pathogenesis	NN
of	IN
IPF	NN
has	VBZ
largely	RB
come	VBN
from	IN
the	DT
use	NN
of	IN
animal	NN
disease	NN
models	NNS
in	IN
rodents	NNS
.	.

Most	JJS
data	NNS
suggest	VBP
,	,
from	IN
among	IN
the	DT
different	JJ
factors	NNS
,	,
a	DT
prominent	JJ
role	NN
for	IN
the	DT
transforming	VBG
growth	NN
factor	NN
(	(
TGF	NN
)	)
-	:
beta1	NN
and	CC
platelet-derived	JJ
growth	NN
factor	NN
pathways	NNS
.	.

Inflammation	NN
is	VBZ
a	DT
critical	JJ
element	NN
of	IN
the	DT
initiation	NN
of	IN
fibrosis	NN
and	CC
data	NNS
indicate	VBP
that	IN
the	DT
Smad	NN
pathway	NN
is	VBZ
a	DT
necessary	JJ
link	NN
to	TO
fibrosis	NN
through	IN
TGF-beta	NN
and	CC
Smad3	NN
signaling	NN
,	,
which	WDT
introduces	VBZ
matrix	NN
regulation	NN
as	IN
a	DT
new	JJ
target	NN
for	IN
therapeutic	JJ
intervention	NN
.	.

Regardless	RB
,	,
gene	NN
targeted	VBN
therapy	NN
has	VBZ
numerous	JJ
pitfalls	NNS
that	WDT
have	VBP
to	TO
be	VB
addressed	VBN
before	IN
we	PRP
see	VBP
a	DT
real	JJ
therapeutic	JJ
advance	NN
.	.

